In the last trading session, 4.01 million shares of the Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) were traded, and its beta was 0.29. Most recently the company’s share price was $1.24, and it changed around $0.0 or 0.40% from the last close, which brings the market valuation of the company to $18.22M. CPIX currently trades at a discount to its 52-week high of $2.36, offering almost -90.32% off that amount. The share price’s 52-week low was $1.04, which indicates that the current value has risen by an impressive 16.13% since then. We note from Cumberland Pharmaceuticals Inc’s average daily trading volume that its 10-day average is 0.3 million shares, with the 3-month average coming to 82.75K.
Cumberland Pharmaceuticals Inc stock received a consensus recommendation rating of Hold, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended CPIX as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.
Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) trade information
Instantly CPIX has showed a green trend with a performance of 0.40% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 1.3700 on recent trading dayincreased the stock’s daily price by 9.49%. The company’s shares are currently down -30.79% year-to-date, but still down -4.62% over the last five days. On the other hand, Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) is 3.33% up in the 30-day period. We can see from the shorts that 89608.0 shares have been sold at a short interest cover period of 1.2 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 0.31%.
CPIX Dividends
Cumberland Pharmaceuticals Inc’s next quarterly earnings report is expected to be released in January.
Cumberland Pharmaceuticals Inc (NASDAQ:CPIX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 44.80% of Cumberland Pharmaceuticals Inc shares, and 14.69% of them are in the hands of institutional investors. The stock currently has a share float of 26.61%. Cumberland Pharmaceuticals Inc stock is held by 25.0 institutions, with RENAISSANCE TECHNOLOGIES LLC being the largest institutional investor. By 2024-06-30, it held 3.8173% of the shares, which is about 0.54 million shares worth $0.82 million.
VANGUARD GROUP INC, with 2.6546% or 0.37 million shares worth $0.57 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
